Literature DB >> 29848685

Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.

Tumenjin Enkhbat1, Masaaki Nishi2, Chie Takasu1, Kozo Yoshikawa1, Higashijima Jun1, Takuya Tokunaga1, Hideya Kashihara1, Daichi Ishikawa1, Mitsuo Shimada1.   

Abstract

BACKGROUND/AIM: Programmed cell death protein 1 (PD-1)/ programmed cell death ligand 1(PD-L1) axis is associated with immune tolerance via inhibition of T cell activation. The aim of this study was to clarify the significance of PD-1 and PD-L1 expressions and analyze the relationships between PD-1, PD-L1, transforming growth factor-β (TGF-β) and Forkhead box P3 (Foxp3) expressions in colorectal cancer (CRC). PATIENTS AND METHODS: A total of 116 patients who underwent curative colectomy for stage II/III CRC were included in the study. PD-1, PD-L1, TGF-β, and Foxp3 expressions were examined by immunohistochemistry and related to prognostic factors by Kaplan-Meier.
RESULTS: PD-1 expression was correlated with PD-L1, TGF-β, and Foxp3 expressions. Overall survival rates were significantly poorer in the PD-1 and PD-L1-positive groups. Multivariate analysis showed that PD-L1-positive is an independent risk factor. Disease-free survival (DFS) was tended in the PD-L1-positive group. The group with double-positive expression had significantly poorer prognosis.
CONCLUSION: PD-1 and PD-L1 expressions were associated with a poor prognosis and correlated with TGF-β and Foxp3 expressions in patients with CRC. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Foxp-3; TGF-β; prognosis; programmed cell death protein 1; programmed death-ligand 1

Mesh:

Substances:

Year:  2018        PMID: 29848685     DOI: 10.21873/anticanres.12603

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy.

Authors:  Ming Zhao; Jing Zhang; Siyu Chen; Yuqi Wang; Qing Tian
Journal:  Cancer Manag Res       Date:  2020-08-04       Impact factor: 3.989

2.  Immunohistochemical Expression of Programmed Death Ligand-1 (PDL-1) in Colorectal carcinoma and Its Correlation with Stromal Tumor Infiltrating Lymphocytes.

Authors:  Mona Elfishawy; Solafa Amin Abd-ELaziz; Azza Hegazy; Dina F El-Yasergy
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

3.  PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer.

Authors:  Tiancheng Zhao; Yezhou Li; Jiayu Zhang; Bin Zhang
Journal:  Oncol Lett       Date:  2020-05-20       Impact factor: 2.967

4.  Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma.

Authors:  Zhenhua Liu; Yisen Meng; Yudong Cao; Yuke Chen; Yu Fan; Shaobo Li; Qun He; Shiliang Wu; Wei Yu; Jie Jin
Journal:  Transl Androl Urol       Date:  2020-04

5.  Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients.

Authors:  Wenqi Bai; Jinfeng Ma; Yangyang Liu; Jing Liang; Yueqin Wu; Xuanqin Yang; Enwei Xu; Yan Li; Yanfeng Xi
Journal:  Cancer Med       Date:  2019-04-03       Impact factor: 4.452

6.  The role of the immunoescape in colorectal cancer liver metastasis.

Authors:  Chie Takasu; Shoko Yamashita; Yuji Morine; Kozo Yoshikawa; Takuya Tokunaga; Masaaki Nishi; Hideya Kashihara; Toshiaki Yoshimoto; Mitsuo Shimada
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

7.  NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer.

Authors:  Tung-Yung Huang; Tung-Cheng Chang; Yu-Tang Chin; Yi-Shin Pan; Wong-Jin Chang; Feng-Cheng Liu; Ema Dwi Hastuti; Shih-Jiuan Chiu; Shwu-Huey Wang; Chun A Changou; Zi-Lin Li; Yi-Ru Chen; Hung-Ru Chu; Ya-Jung Shih; R Holland Cheng; Alexander Wu; Hung-Yun Lin; Kuan Wang; Jacqueline Whang-Peng; Shaker A Mousa; Paul J Davis
Journal:  Cells       Date:  2020-08-03       Impact factor: 6.600

8.  Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.

Authors:  Phillip M Kemp Bohan; Robert C Chick; Annelies T Hickerson; Lynn M Messersmith; Grant M Williams; Jessica L Cindass; Jamie Lombardo; Ryan Collins; Robert O Brady; Diane F Hale; George E Peoples; Timothy J Vreeland; Guy T Clifton
Journal:  Cancer Immunol Immunother       Date:  2020-11-12       Impact factor: 6.630

9.  Impact of sidedness of colorectal cancer on tumor immunity.

Authors:  Chie Takasu; Masaaki Nishi; Kozo Yoshikawa; Takuya Tokunaga; Hideya Kashihara; Toshiaki Yoshimoto; Mitsuo Shimada
Journal:  PLoS One       Date:  2020-10-12       Impact factor: 3.240

10.  Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis.

Authors:  Shuxia Wang; Bo Yuan; Yun Wang; Mingyang Li; Xibo Liu; Jing Cao; Changtian Li; Jihong Hu
Journal:  Int J Colorectal Dis       Date:  2020-09-10       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.